PRODUCT INFORMATION
Description
iRGD peptide (Cys-Arg-Gly-Asp-Lys-Gly-Pro-Asp-Cys) is the archetypal tumor-penetrating peptide. It targets αv integrins and is subsequently cleaved to expose a C-end Rule (CendR) motif, which binds to neuropilin-1 to enhance tissue penetration. It is used in research models to improve the distribution of co-administered agents and exhibits inherent anti-migratory activities in vitro.
Molecular Weight
1064.08
Purity
> 95%
Formula
C₃₇H₆₀F₃N₁₃O₁₆S₂
Product Type
Targeting Peptide
Sequence
Cys-Arg-Gly-Asp-Lys-Gly-Pro-Asp-Cys
Form (20 deg.C)
Solid
Storage Condition
Store sealed at -20°C, away from moisture.
For Research Use Only | Not For Clinical Use
Related products
- Cyclo(Arg-Gly-Asp-D-Phe-Cys) TFA Targeting Peptide (CAT#: OLY-1025-YS-68)
- Cyclic SSTR Agonist Octreotide (CAT#: OLY-1025-YS-39)
- CGGK Targeting Peptide (CAT#: OLY-1025-YS-27)
- Octreotide Targeting Peptide (CAT#: OLY-1025-YS-3)
- FFAGLDD Targeting Peptide (CAT#: OLY-1025-YS-43)
- Osteocalcin (1-49) (human) Targeting Peptide (CAT#: OLY-1025-YS-9)
- rTAT Targeting Peptide (CAT#: OLY-1025-YS-20)
- GB-6 Targeting Peptide (CAT#: OLY-1025-YS-11)
Online Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.